Prehabilitation for patients with osteoarthritis of the hip or knee waiting for a total Joint replacement for hip or knee

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00009239

Enrollment

Registered

2015-10-14

Start date

2015-08-10

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M16 M17

Interventions

Group 1: The intervention group which takes part in a 4-week training programme. This programme consists of 8 sessions medical training therapy (60 minutes), 4 sessions therapy in the pool (30 min) an

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: osteoarthritis of the hip or knee

Exclusion criteria

Exclusion criteria: Alzheimer's disease, dementia, disability to speak and understand German, serious neurological disorders, disability to walk at least 3 m

Design outcomes

Primary

Measure	Time frame
The knee and hip patients as well as the patients with and without training programme estimate their pain using the VAS before the intervention (and the beginning of the training programme) (t = 0), after the end of the training programme (t = 1) and after 6 weeks, 3 months and 6 months (t = 2, 3, 4) postal-surgically. Two primary hypotheses are examined: comparison of the mean change of the pain sensation (t = 0 to t = 2) in the therapy (VAS20t) and the control group (VAS20k) for patients with hip TJR and for patients with knee TJR: null hypothesis (H0): VAS20t = VAS20k alternative hypothesis (H1): VAS20t ? VAS20k	—

Measure

Time frame

The knee and hip patients as well as the patients with and without training programme estimate their pain using the VAS before the intervention (and the beginning of the training programme) (t = 0), after the end of the training programme (t = 1) and after 6 weeks, 3 months and 6 months (t = 2, 3, 4) postal-surgically. Two primary hypotheses are examined: comparison of the mean change of the pain sensation (t = 0 to t = 2) in the therapy (VAS20t) and the control group (VAS20k) for patients with hip TJR and for patients with knee TJR: null hypothesis (H0): VAS20t = VAS20k alternative hypothesis (H1): VAS20t ? VAS20k

—

Secondary

Measure	Time frame
Besides of the comparison of the pain reductions in two groups, the following research questions are examined: 1) Development of the values VAS (estimation of pain) over the time 2) Development of the ROM values (mobility of knee (extension und flexion) and hip (extension, flexion and abduction)) 3) Investigation of the values of KOOS (questionnaire of knee specific quality of life), HOOS (questionnaire of hip specific quality of life), SF-36 (questionnaire of general quality of life), timed-up-and-go-test (mobility), chair stand test (strength of the legs) and 40 m (speed test) and 6 min walking tests (walking endurance) Assessments are conducted before (t=0) and after ((t=1) the programme and 6 weeks (t=2), 3 (t=3) and 6 (t=4) months after surgery.	—

Measure

Time frame

Besides of the comparison of the pain reductions in two groups, the following research questions are examined: 1) Development of the values VAS (estimation of pain) over the time 2) Development of the ROM values (mobility of knee (extension und flexion) and hip (extension, flexion and abduction)) 3) Investigation of the values of KOOS (questionnaire of knee specific quality of life), HOOS (questionnaire of hip specific quality of life), SF-36 (questionnaire of general quality of life), timed-up-and-go-test (mobility), chair stand test (strength of the legs) and 40 m (speed test) and 6 min walking tests (walking endurance) Assessments are conducted before (t=0) and after ((t=1) the programme and 6 weeks (t=2), 3 (t=3) and 6 (t=4) months after surgery.

—

Countries

Germany

Contacts

Public ContactDaniela Oestreich

Asklepios Klinik St. Georg Sporttherapie/ Abteilung für Frührehabilitation und physikalische Medizin

d.oestreich@asklepios.com+49 - 40 - 1818 854532

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026